Clementi Ltd. has a new website at regulatoryaffairs.com.
The firm has supported pharmaceutical and emerging biotechnology companies since 1991. Sponsors come to Clementi for regulatory strategy, FDA meetings and submissions on advanced therapies, including tissue-based products, peptides, large molecules, biologics and drug-device combinations. An in-house submissions group handles the filing work. The firm reports more than 1,000 FDA submissions in recent years and more than 100 INDs.
That range has to be readable on one visit. The new site is a single responsive page. A rotating hero states the firm’s positions, including model-informed drug development, real-world evidence and novel preclinical models. An illustrated section, “Where Every Piece Has a Purpose,” connects the parts of a development program: eCTD and IND work, CMC, toxicology, clinical protocol, document management, FDA meetings, GLP and monitoring audits.
Service cards cover FDA submissions, document management, CMC development and advanced therapies. The page introduces the team and ends with a consultation form. Design is by Gdovindesigns. A + L Development designed and programmed the site.
The project is on our Clementi Ltd. work page.